Cymbalta® Withdrawal
What is Cymbalta Withdrawal?
Cymbalta withdrawal refers to the symptoms a person experiences when they stop taking Cymbalta, also called discontinuation-emergent adverse events (“DEAEs”).
The frequency of Cymbalta withdrawal is associated with a drug’s “half-life.” The term “half-life” means the amount of time it takes for half of the drug to be eliminated from the body after one stops taking it. In his book, The Antidepressant Solution, Dr. Joseph Glenmullen, a clinical instructor in psychiatry
at Harvard, explains that “the frequency with which antidepressants cause withdrawal reactions correlates with how short their half-lives are.” When a drug has a short half-life, the drug begins to exit the patients system very quickly, and that sudden depletion of the drug in the patient’s body, leads to withdrawal. Conversely, drugs that have a long half-life, leave the body gradually and generally have less frequent and severe withdrawal effects.
Common side effects of Cymbalta withdrawal:
- Extreme mood swings
- Agitation and/or irritability
- Aggression
- Nightmares and/or sleep disturbance
- Confusion
- Diarrhea
- Vertigo
- Dizziness and/or light-headedness
- Headache and/or migraines
- Nausea and/or vomiting
- Excessive sweating
- Memory and concentration difficulties
- Suicidal thoughts (ideation)
- Suicide attempts
- Self-mutilation
- Hallucination and/or sensory disturbances
- Tremors
- Seizures
- Fatigue
- Lethargy
- Flu-like symptoms (abdominal discomfort, weakness, etc.)
- Body zaps – electronic shock-like sensations in body (not in head)
- Brain zaps – electric shock-like sensations in head
Cymbalta Half-Life
Cymbalta has an extremely short half-life of about twelve hours. This means that, on average, when taking Cymbalta, half of the drug leaves the patient’s system within twelve hours. This is an extremely fast rate. And, among antidepressants, Cymbalta is the second fastest. With such a short half-life, you would expect Cymbalta users to experience very high rates of withdrawal effects. You would also hope that the manufacturer of Cymbalta would properly warn patients and their physicians about this serious risk through the drug label and in Cymbalta advertising.
We are no longer accepting Cymbalta cases.
How Severe are Cymbalta Withdrawal Effects?
According to Lilly’s own clinical trials, in many cases, Cymbalta withdrawal reactions were moderate to severe. In the short term trials, one out of every ten patients experienced severe reactions. In one 52-week trial, at least one in six patients was severely affected. In another study, 25% of those who experienced withdrawal effects had severe reactions.
In 2008, the Annals of Clinical Psychiatry published a report of a 26-year-old woman who was so traumatized by the nausea, dizziness, and “electric shocks inside the head” when she tried to withdraw from Cymbalta that she requested to be put on another antidepressant immediately and “expressed a real fear of having these shock-like reactions again.” The authors observed that, “Antidepressants with a short half-life tend to be associated with a significant rate of DEAEs and a higher severity level” (emphasis added).
Cymbalta withdrawal effects, including extreme mood swings (anger, irritability), debilitating brain zaps, and physical and neurological problems, can be severe and extend for weeks and even months. The volume of patient complaints and the severity of the symptoms reported on multiple websites (including on such websites as the People’s Pharmacy and Depression Forums) leaves little doubt about the seriousness of Cymbalta withdrawal. In many patients, Cymbalta creates what amounts to a physical dependence that makes it nearly impossible to quit taking the drug.
We are no longer accepting Cymbalta cases.
Our Case Results
-
$10 Million Settlement A Major Foreign Plane Crash
Wisner Baum obtained a $10 million settlement for the death of a passenger in a major foreign plane crash.
-
$14 Million Settlement A Major US Plane Crash
Wisner Baum obtained a $14 million settlement for the death of a passenger in a major US plane crash.
-
$17.5 Million Settlement A Major US Plane Crash
Wisner Baum obtained a $17.5 million settlement on behalf of a client who was killed in a major U.S. plane crash.
-
$10 Million Settlement Celexa-Lexapro Pediatric Class Action
$10 million pediatric class action re false promotion of Celexa and Lexapro. Babies born to women who have used Lexapro and other similar medications such as Zoloft, Celexa, Prozac, Paxil, and Symbyax are at an increased risk for birth defects.
-
$8.5 Million Verdict Commercial Truck Accident
Wisner Baum secured a $8.5 million wrongful death verdict against the food industry company, Tyson Foods, for the wrongful death of a young man.
-
$28 Million Settlement Defective Drug Class Action
$28 million Paxil defective drug class action. A class action has been brought in the US territory of Puerto Rico against UK-based drug major GlaxoSmithKline.
Client-Focused Representation
REVIEWS & TESTIMONIALS
We believe our track record speaks for itself. But you don’t have to take our word for it. See what our clients have to say about working with us.
-
"I Can’t Imagine a Better Law Firm"
Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.
- Best Law Firms Survey -
"They Are About Changing the Systems..."
Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.
- Kim Witczak -
"Top Legal Minds in the Country"
The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.
- From Best Lawyers® Best Law Firms
